Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Research in Pharmaceutical Sciences is Scopus-indexed (Q2, CiteScore 4.1), WoS ESCI, DOAJ. Published by Wolters Kluwer Medknow Publications.
Checked against the index lists dated .
ISSN 1735-5362Verify ISSN ↗1735-9414Verify ISSN ↗
Publisher: Wolters Kluwer Medknow Publications
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 21 / 79 | 74th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q2, CiteScore 4.1.
Research in Pharmaceutical Sciences is Q2 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 21 of 79), by CiteScore 2025.
Research in Pharmaceutical Sciences is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.1, which places it in quartile Q2 at the 74th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.540, quartile Q2, with an H-index of 50.
The publisher lists an article processing charge of about US$500 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Research in Pharmaceutical Sciences is published by Wolters Kluwer Medknow Publications. Its print ISSN is 1735-5362 and its online ISSN is 1735-9414.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Research in Pharmaceutical Sciences has an h-index of 36 and a 2-year mean of 2.39 citations per paper (OpenAlex). Its Scopus CiteScore is 4.1, quartile Q2. On 2-year citations it ranks #25 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
Research in Pharmaceutical Sciences published 70 papers in 2025; its busiest recent year was 2017 with 71. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from Iran (73.7%), Indonesia (4.5%) and United States (1.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.